Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Houston Eye Associates (HEA) is the largest multi-specialty ophthalmology practice in the United States, providing comprehensive eye care services across the Greater Houston area. Founded in 1969, the organization consists of over 50 board-certified ophthalmologists and optometrists specializing in nearly every sub-specialty of eye care, including retina, glaucoma, cornea, and pediatrics. Beyond clinical practice, HEA maintains a robust clinical research department that serves as a primary site for industry-sponsored Phase 1 through Phase 4 clinical trials for novel ophthalmic drugs and surgical devices. The company operates numerous clinical locations, several ambulatory surgery centers, and a dedicated optical department to offer integrated patient care. In 2020, Houston Eye Associates partnered with EyeCare Partners, a leading clinically-led network of ophthalmology and optometry practices.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Houston Eye Associates.